BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12182024)

  • 1. [Radical surgical treatment of differentiated thyroid cancer--necessity or over-enthusiasm?].
    Nowak W; Szybiński P
    Wiad Lek; 2001; 54 Suppl 1():189-97. PubMed ID: 12182024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical complications after total thyroidectomy and resections for differentiated thyroid carcinoma.
    Sand J; Palkola K; Salmi J
    Ann Chir Gynaecol; 1996; 85(4):305-8. PubMed ID: 9014059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical treatment of well-differentiated carcinoma of the thyroid.
    Ontai S; Straehley CJ
    Am Surg; 1985 Nov; 51(11):653-7. PubMed ID: 4062059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
    Saadi H; Kleidermacher P; Esselstyn C
    Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
    Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Br J Surg; 2007 May; 94(5):571-7. PubMed ID: 17279493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
    Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
    Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
    Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
    Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.